MOH — authorised 3 July 1979
- Marketing authorisation holder: JACOBUS
- Status: likely_approved
🇮🇱 Aczone in Israel
MOH authorised Aczone on 3 July 1979
Marketing authorisations
MOH — authorised 4 April 2025
- Marketing authorisation holder: AUROBINDO PHARMA LTD
- Status: likely_approved
MOH — authorised 23 April 2025
- Marketing authorisation holder: NOVITIUM PHARMA
- Status: likely_approved
Aczone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Israel
Frequently asked questions
Is Aczone approved in Israel?
Yes. MOH authorised it on 3 July 1979; MOH authorised it on 4 April 2025; MOH authorised it on 23 April 2025.
Who is the marketing authorisation holder for Aczone in Israel?
JACOBUS holds the Israeli marketing authorisation.